Dattoli Participates in Mount Sinai


(April 5, 2010 – Sarasota, FL)

Dr. Michael Dattoli, founder and physician-in-chief of the Dattoli Cancer Center & Brachytherapy Research Institute in Sarasota, has just returned from speaking to a group of physicians at Mount Sinai School of Medicine in New York City.

Dattoli participated in the Rudin-Kase Dean’s Lecture Series, which is held to update current faculty on the leading-edge work of its outstanding alumni.

A graduate of the esteemed medical school, radiation oncologist Dattoli has concentrated on non-surgical approaches for prostate cancer for more than 20 years. He and partner Richard Sorace, MD, PhD, have developed a combination therapy utilizing sophisticated external beam radiation (developed as Dynamic Adaptive RadioTherapy or DART at the Dattoli Cancer Center) and Brachytherapy (seed implant). This combination therapy has been studied and followed for close to 18 years.

In 2009, Dr. Dattoli published what is the longest standing study of prostate cancer patients treated with by one physician. This 16-year study reveals a remarkably high cure rate and equally impressive low side effect profiles. The study group of 321 patients were classified as intermediate and high risk according to their Gleason scores and PSA levels. Despite their risk categories, these patients demonstrated an aggregate cure level of 82% after 16 years.

This study was a part of the Rudin-Kase presentation, along with Dattoli’s review of the combination treatment protocol in comparison to other main-stream treatment options, and a look at what the future may hold for prostate cancer patients upon first diagnosis, as well as those 50,000 who will experience a recurrence of their cancer each year.

The Dattoli Cancer Center was established in 2001 in Sarasota, Florida as the first privately held, independent center for the exclusive treatment of prostate cancer. An average of 500 men are seen at the Center each year, many traveling from great distances to avail themselves of the Dattoli non-surgical treatment.

Contact Us